Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

8dc52f820.iDAAAxDfiD5n53veT1hdQQn0Qn5-8NjMrGq77Lr1WNk.30l6bnqR3VoukjisIjU0M06ALA0Yopy_xSv9ltWhM-zxaGprWJbFeynWQw~283989c213596656472ef9a92fd162a7
11-25 Forvia revises EPS outlook after non-cash charge Alphavalue
10-21 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
10-21 Forvia: UBS still neutral after quarterly results Zonebourse
10-20 FORVIA : Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
09-12 The stock market regains its cloak of invincibility Zonebourse
08-07 FORVIA : Opinion change, from Sell to Reduce Alphavalue
07-30 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
07-29 FORVIA : Deutsche Bank downgrades stock Zonebourse
07-29 FORVIA : Solid H1 results ahead of expectations, FY25 guidance confirmed Alphavalue
07-29 FORVIA : Oddo BHF raises target price Zonebourse
07-24 FORVIA : NAV cut by -14.8% Alphavalue
07-03 FORVIA : Target upgrade by 14.5% Alphavalue
06-27 FORVIA : Berenberg still a buyer, seeing positive surprises Zonebourse
04-22 FORVIA : Receives a Buy rating from Deutsche Bank ZD
04-22 FORVIA : Oddo BHF lowers target price Zonebourse
04-17 FORVIA : Stronger than expected Q1 and FY25 guidance maintained despite tariff risks Alphavalue
04-01 FORVIA : Opinion change, from Buy to Reduce Alphavalue
03-26 TP Icap Midcap Kicks Off Forvia Coverage with Hold Rating MT
03-26 FORVIA : TP ICAP Midcap initiates coverage on hold Zonebourse
03-19 FORVIA : UBS reaffirms its Neutral rating ZD
03-06 FORVIA : Soft FY24 results amid a tough environment, weaker than expected FY25 guidance Alphavalue
24/10/24 FORVIA : Forvia posts solid Q3 results amidst a challenging automotive market Alphavalue
22/10/24 FORVIA : UBS reiterates its buy recommendation on the stock Zonebourse
30/09/24 FORVIA : UBS remains Buy on the stock Zonebourse
30/09/24 FORVIA : Barclays remains positive, lowers target Zonebourse
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.52%
+17.65%
-6.42%
+26%
+14.55%
+7.99%
+28.51%
+9.49%
+10.96%
+0.67%
Average +11.79%
Weighted average by Cap. +11.64%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
12.90EUR
Average target price
13.75EUR
Spread / Average Target
+6.55%
High Price Target
39.00EUR
Spread / Highest target
+202.21%
Low Price Target
8.500EUR
Spread / Lowest Target
-34.13%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Adrien Brasey
TP ICAP Midcap
UBS David Lesne
Stifel Nicolaus
Berenberg Bank
GOLDMAN SACHS Philipp Konig
JEFFERIES Himanshu Agarwal
DEUTSCHE BANK RESEARCH Christoph Laskawi
JPMORGAN Jose Asumendi
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
12.90EUR
Average target price
13.75EUR
Spread / Average Target
+6.55%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)